279 related articles for article (PubMed ID: 16567401)
41. Destructive proteolysis by cysteine proteases in antigen presentation of ovalbumin.
Rodriguez GM; Diment S
Eur J Immunol; 1995 Jul; 25(7):1823-7. PubMed ID: 7621859
[TBL] [Abstract][Full Text] [Related]
42. Cathepsins D, B, and L in malignant human lung tissue.
Ledakis P; Tester WT; Rosenberg N; Romero-Fischmann D; Daskal I; Lah TT
Clin Cancer Res; 1996 Mar; 2(3):561-8. PubMed ID: 9816204
[TBL] [Abstract][Full Text] [Related]
43. Cathepsin D is partly endocytosed by the LRP1 receptor and inhibits LRP1-regulated intramembrane proteolysis.
Derocq D; Prébois C; Beaujouin M; Laurent-Matha V; Pattingre S; Smith GK; Liaudet-Coopman E
Oncogene; 2012 Jun; 31(26):3202-12. PubMed ID: 22081071
[TBL] [Abstract][Full Text] [Related]
44. Pathophysiological functions of cathepsin D: Targeting its catalytic activity versus its protein binding activity?
Masson O; Bach AS; Derocq D; Prébois C; Laurent-Matha V; Pattingre S; Liaudet-Coopman E
Biochimie; 2010 Nov; 92(11):1635-43. PubMed ID: 20493920
[TBL] [Abstract][Full Text] [Related]
45. Potential role of lysosomal proteases in gentamicin nephrotoxicity.
Olbricht CJ; Gutjahr E; Fink M; Koch KM
Adv Exp Med Biol; 1988; 240():305-8. PubMed ID: 3245493
[No Abstract] [Full Text] [Related]
46. Cathepsin L in glioma progression: comparison with cathepsin B.
Strojnik T; Kavalar R; Trinkaus M; Lah TT
Cancer Detect Prev; 2005; 29(5):448-55. PubMed ID: 16183211
[TBL] [Abstract][Full Text] [Related]
47. Overexpression of both catalytically active and -inactive cathepsin D by cancer cells enhances apoptosis-dependent chemo-sensitivity.
Beaujouin M; Baghdiguian S; Glondu-Lassis M; Berchem G; Liaudet-Coopman E
Oncogene; 2006 Mar; 25(13):1967-73. PubMed ID: 16331270
[TBL] [Abstract][Full Text] [Related]
48. Cathepsin L is responsible for processing and activation of proheparanase through multiple cleavages of a linker segment.
Abboud-Jarrous G; Atzmon R; Peretz T; Palermo C; Gadea BB; Joyce JA; Vlodavsky I
J Biol Chem; 2008 Jun; 283(26):18167-76. PubMed ID: 18450756
[TBL] [Abstract][Full Text] [Related]
49. Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis.
Lah TT; Kalman E; Najjar D; Gorodetsky E; Brennan P; Somers R; Daskal I
Hum Pathol; 2000 Feb; 31(2):149-60. PubMed ID: 10685628
[TBL] [Abstract][Full Text] [Related]
50. Release of endo-lysosomal cathepsins B, D, and L from IEC6 cells in a cell culture model mimicking intestinal manipulation.
Mayer K; Vreemann A; Qu H; Brix K
Biol Chem; 2009; 390(5-6):471-80. PubMed ID: 19284293
[TBL] [Abstract][Full Text] [Related]
51. Function of liver activation-regulated chemokine/CC chemokine ligand 20 is differently affected by cathepsin B and cathepsin D processing.
Hasan L; Mazzucchelli L; Liebi M; Lis M; Hunger RE; Tester A; Overall CM; Wolf M
J Immunol; 2006 Jun; 176(11):6512-22. PubMed ID: 16709808
[TBL] [Abstract][Full Text] [Related]
52. Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages.
Punturieri A; Filippov S; Allen E; Caras I; Murray R; Reddy V; Weiss SJ
J Exp Med; 2000 Sep; 192(6):789-99. PubMed ID: 10993910
[TBL] [Abstract][Full Text] [Related]
53. [Proteases participating in metamorphosis of flesh fly (Sarcophaga peregrina)].
Homma K
Seikagaku; 1997 Apr; 69(4):259-64. PubMed ID: 9168679
[No Abstract] [Full Text] [Related]
54. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
[TBL] [Abstract][Full Text] [Related]
55. Differentiation-induced changes in the content, secretion, and subcellular distribution of lysosomal cathepsins in the human colon cancer HT-29 cell line.
De Stefanis D; Démoz M; Dragonetti A; Houri JJ; Ogier-Denis E; Codogno P; Baccino FM; Isidoro C
Cell Tissue Res; 1997 Jul; 289(1):109-17. PubMed ID: 9182605
[TBL] [Abstract][Full Text] [Related]
56. Pro-cathepsin D interacts with the extracellular domain of the beta chain of LRP1 and promotes LRP1-dependent fibroblast outgrowth.
Beaujouin M; Prébois C; Derocq D; Laurent-Matha V; Masson O; Pattingre S; Coopman P; Bettache N; Grossfield J; Hollingsworth RE; Zhang H; Yao Z; Hyman BT; van der Geer P; Smith GK; Liaudet-Coopman E
J Cell Sci; 2010 Oct; 123(Pt 19):3336-46. PubMed ID: 20826454
[TBL] [Abstract][Full Text] [Related]
57. Biological and clinical significance of cathepsin D in breast cancer metastasis.
Garcia M; Platet N; Liaudet E; Laurent V; Derocq D; Brouillet JP; Rochefort H
Stem Cells; 1996 Nov; 14(6):642-50. PubMed ID: 8948022
[TBL] [Abstract][Full Text] [Related]
58. Lysosomal peptidases and glycosidases in rheumatoid arthritis.
Sohar N; Hammer H; Sohar I
Biol Chem; 2002 May; 383(5):865-9. PubMed ID: 12108554
[TBL] [Abstract][Full Text] [Related]
59. Effects of cysteine protease inhibitors on rabbit cathepsin D maturation.
Samarel AM; Ferguson AG; Decker RS; Lesch M
Am J Physiol; 1989 Dec; 257(6 Pt 1):C1069-79. PubMed ID: 2610247
[TBL] [Abstract][Full Text] [Related]
60. Expression of cathepsin B, D and L protein in juvenile idiopathic arthritis.
Taubert H; Riemann D; Kehlen A; Meye A; Bartel F; John V; Brandt J; Bache M; Würl P; Schmidt H; Weber E
Autoimmunity; 2002 May; 35(3):221-4. PubMed ID: 12389647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
